Restasis en es it fr

Restasis Brand names, Restasis Analogs

Restasis Brand Names Mixture

  • No information avaliable

Restasis Chemical_Formula


Restasis RX_link

Restasis fda sheet

Restasis FDA

Restasis msds (material safety sheet)

Restasis Synthesis Reference

No information avaliable

Restasis Molecular Weight


Restasis Melting Point

No information avaliable

Restasis H2O Solubility

No information avaliable

Restasis State


Restasis LogP


Restasis Dosage Forms

Capsule (liquid-filled); Capsule (liquid-filled for emulsion); Solution (oral); Solution (IV infusion)

Restasis Indication

For treatment of transplant rejection, rheumatoid arthritis, severe psoriasis

Restasis Pharmacology

Used in immunosuppression for prophylactic treatment of organ transplants, cyclosporine exerts specific and reversible inhibition of immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited. The T1-helper cell is the main target, although the T1-suppressor cell may also be suppressed. Sandimmune (cyclosporine) also inhibits lymphokine production and release including interleukin-2.

Restasis Absorption

No information avaliable

Restasis side effects and Toxicity

No information avaliable

Restasis Patient Information


Restasis Organisms Affected

Humans and other mammals